Plain-English translation of ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether high-flow oxygen therapy — delivered through a special nasal cannula at different oxygen levels — can help treat and prevent complications from vaso-occlusive pain crises in adults with sickle cell disease. Vaso-occlusive crises are episodes of severe pain caused by sickle cells blocking blood vessels. Researchers want to know if the medication can stop the crisis from getting worse and prevent a serious complication called acute chest syndrome.
Currently, doctors treat sickle cell pain crises mainly by managing symptoms with pain medication and regular oxygen, but there is no proven way to stop the crisis itself or prevent it from developing into acute chest syndrome, which is the leading cause of death in adults with sickle cell disease. This trial is testing whether a newer, more intensive oxygen therapy approach might work better.
You likely qualify if…
You likely don't qualify if…
If you join this trial during a pain crisis, you will be randomly assigned to receive one of four types of oxygen therapy through a nasal cannula: standard low-flow oxygen, or high-flow oxygen at different oxygen levels. You will receive your assigned treatment in the hospital from admission until you are discharged or until a complication develops. The research team will monitor your oxygen levels, symptoms, and overall condition throughout your hospital stay to see which approach works best and is safest.
AI-generated summary from trial data · Jun 12, 2026 · Not medical advice
France